Evidence map›Paper›PMID 34675329›Full record

ArticleScientific reports2021

Author Correction: Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation.

Yukako Ohyama, Hisateru Yamaguchi, Kazuki Nakajima, Tomohiro Mizuno, Yukihiro Fukamachi, Yasuto Yokoi, Naotake Tsuboi, Daijo Inaguma, Midori Hasegawa, Matthew B Renfrow and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Yukako OhyamaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Hisateru YamaguchiInstitute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan.
Kazuki NakajimaCenter for Research Promotion and Support, Fujita Health University, Toyoake, Japan.
Tomohiro MizunoAnalytical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Yukihiro FukamachiMitsui Knowledge Industry, Tokyo, Japan.
Yasuto YokoiMitsui Knowledge Industry, Tokyo, Japan.
Naotake TsuboiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Daijo InagumaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.ORCID https://orcid.org/0000-0002-3977-5933
Midori HasegawaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Matthew B RenfrowDepartments of Biochemistry and Molecular Genetics and Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID https://orcid.org/0000-0002-4193-7305
Jan NovakDepartments of Biochemistry and Molecular Genetics and Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID https://orcid.org/0000-0002-9211-6670
Yukio YuzawaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Kazuo TakahashiDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan. kazuot@fujita-hu.ac.jp.

Funding

Molecular Basis of Pathogenicity of IgA1-containing Immune ComplexesR01DK078244 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JAN NOVAK · 2007 to 2026
$6.0M
NIDDK NIH HHS R01 DK078244
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34675329
PMCPMC8531025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.